Search Results for: Probiotic

by Noelle Patno, PhD L. plantarum 299v is a probiotic globally recognized for having Level 2 evidence for the improvement in severity of abdominal pain in irritable bowel syndrome and a large study preventing C. diffficile-associated diarrhea in antibiotic-treated patients.1 A new review2 on the 30-year anniversary of the isolation of this strain was recently published summarizing the current knowledge on this unique probiotic strain. This article features the main highlights of the reviewed science on probiotic strain Lactobacillus plantarum 299v.  Characteristics of the strain: 2  Plant-derived. L. plantarum 299v belongs to the group of lactic acid bacteria, and these types are commonly…

While a meta-analysis shows that probiotics reduce the duration of the common cold by an average of 1.89 days, Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 team up to reduce the duration of the common cold by as much as 2.4 days in one study. This research review covers mechanisms of action in multiple clinical trials as well as four double-blind randomized clinical trials on the common cold using 1 billion colony-forming units of this probiotic combination. Download the PDF

Probiotic Strain L. paracasei Lpc-37® Reduced Stress in Healthy Adults Scientists have been searching for “psychobiotics,” probiotics that can modify the gut-brain axis,1 and now a recent publication using a robust clinical trial design demonstrated a probiotic strain that improved the stress response. Previous preclinical studies demonstrated that Lacticaseibacillus paracasei Lpc-37 (Lpc-37), formerly known as Lactobacillus paracasei Lpc-37 prevented the development of certain behaviors associated with chronic stress.2 This “psychobiotic” candidate was selected from other probiotic strains for clinical effects on perceived stress…

Single-strain and multistrain probiotics can be beneficial for specific clinical applications.1,2 Potential advantages of multistrain probiotic supplements are a broader spectrum of health benefits (compared to intake of a single probiotic strain) and synergistic effects of the individual probiotic strains.2 Clinical trial results on a new, high colony-forming units (CFU) count combination of 8 strains of Lactobacillus and Bifidobacterium probiotics were recently published in Integrative Medicine: A Clinician’s Journal.3 The study evaluated the short-term impact of consumption of one capsule…

by Melissa Blake, ND Immune resilience has never been more important or desired than in the past year. As a result of a global pandemic, patients and practitioners alike are seeking effective solutions to ensure a robust immune defense. Outside of the current COVID-19 concerns, respiratory tract infections (RTIs) pose a significant burden and are, in children, elderly, and immunocompromised individuals, the most prevalent diseases globally.1 A well-balanced gut microbiota is associated with protection against various diseases, including respiratory infections,…

This is a recording of a presentation given by Dr. Noelle Patno and Dr. Jennifer Ryan in June 2020, at the “Next Gen Microbiome and Probiotics” virtual conference. This presentation includes an overview of specific microbiota, F. prausnitzii and A. muciniphila, that have been described as next generation microbes and bioindicators of health. Challenges for delivering these microbiota directly as probiotic supplements are also explained. Dietary modification, prebiotics, and supplementation with specific strains of Lactobacillus and Bifidobacterium are described as…